Tempus announces its new TIME service to boost participation in cancer clinical trials.
NESTcc says it is launching 12 new test cases to provide proof of concept for its ability to generate high-quality real-world evidence for a range of ...
ECA Academy analyzes an FDA Warning Letter raising cleaning/disinfection issues.
Hamilton Medical updates all Hamilton-G5 Ventilators that contain software versions 2.60 or older to prevent the user message panel connection lost an...
FDA approves an Eli Lilly BLA for Emgality (galcanezumab-gnlm) solution for injection for treating episodic cluster headache in adults.
HHS explains its decision to stop funding research that uses fetal tissue from elective abortions.
FDA accepts for review an Enzyvant BLA for RVT-802, a novel investigational tissue-based regenerative therapy designed to treat pediatric congenital a...
FDA approves a Zavation 510(k) to market the Ti3Z Interbody System, a lumbar intervertebral body fusion device.